Penumbra, Inc Deferred Foreign Income Tax Expense (Benefit)
Penumbra, Inc (PEN) reported Deferred Foreign Income Tax Expense (Benefit) of $221.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-25
- Penumbra, Inc deferred foreign income tax expense (benefit) for fiscal 2025 was $221.00K.
- Penumbra, Inc deferred foreign income tax expense (benefit) for fiscal 2024 was -$404.00K.
- Penumbra, Inc deferred foreign income tax expense (benefit) for fiscal 2023 was -$1.25M.
- Penumbra, Inc deferred foreign income tax expense (benefit) for fiscal 2022 was -$476.00K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $221.00K 10-K · filed 2026-02-25 |
| 2024-12-31 | -$404.00K 10-K · filed 2026-02-25 |
| 2023-12-31 | -$1.25M 10-K · filed 2026-02-25 |
| 2022-12-31 | -$476.00K 10-K · filed 2025-02-18 |
| 2021-12-31 | -$124.00K 10-K · filed 2024-02-22 |
| 2020-12-31 | -$106.00K 10-K · filed 2023-02-23 |
| 2019-12-31 | -$474.00K 10-K · filed 2022-02-22 |
| 2018-12-31 | -$359.00K 10-K · filed 2021-02-23 |
| 2017-12-31 | -$352.00K 10-K · filed 2020-02-26 |
| 2016-12-31 | -$193.00K 10-K · filed 2019-02-26 |
| 2015-12-31 | $25.00K 10-K · filed 2018-02-27 |
| 2014-12-31 | -$117.00K 10-K · filed 2017-02-28 |
| 2013-12-31 | $0.00 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |